Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Capstone Therapeutics Corp. (CAPS : NSDQ)
 
 • Company Description   
Capstone Holding Corp. primary business activities presently include the operations of TotalStone LLC, a construction materials company. Capstone Holding Corp. is headquartered in Alsip, Illinois.

Number of Employees: 38

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.51 Daily Weekly Monthly
20 Day Moving Average: 75,004 shares
Shares Outstanding: 0.16 (millions)
Market Capitalization: $0.24 (millions)
Beta: -0.82
52 Week High: $15.10
52 Week Low: $1.40
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -20.53% -24.83%
12 Week -37.56% -47.62%
Year To Date -32.59% -36.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5141 W. 122nd Street
-
Alsip,IL 60803
USA
ph: 708-371-0660
fax: 602-286-5300
investors@capstoneholdingcorp.com http://www.capstonethx.com
 
 • General Corporate Information   
Officers
Matthew E.Lipman - Chief Executive Officer
Michael Toporek - Chairman
Edward Schultz - Chief Financial Officer
John M.Holliman - Director
Gordon Strout - Director

Peer Information
Capstone Therapeutics Corp. (CSRLY)
Capstone Therapeutics Corp. (ARRD)
Capstone Therapeutics Corp. (CGMCQ)
Capstone Therapeutics Corp. (CMCJY)
Capstone Therapeutics Corp. (OMRP)
Capstone Therapeutics Corp. (ABLT)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: BLDG&CONST-MISC
Sector: Construction
CUSIP: 14068E208
SIC: 5030
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/21/25
Share - Related Items
Shares Outstanding: 0.16
Most Recent Split Date: 9.00 (0.00:1)
Beta: -0.82
Market Capitalization: $0.24 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/21/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.01
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -12.76%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - 1.14
12/31/24 - 1.02
Quick Ratio
06/30/25 - -
03/31/25 - 0.47
12/31/24 - 0.25
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -4.73
Book Value
06/30/25 - -
03/31/25 - 171.13
12/31/24 - -19.40
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 7.33
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.28
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - 21.85
12/31/24 - -
 

Powered by Zacks Investment Research ©